← Back to all trials
Completed
NCT06965959
Effects of Exergaming and Autogenic Relaxation on Psychological Well-Being in Nursing Home Residents
Conditions: Psychological Well-being, Nursing Homes Residents, Aging, Exergaming, Mind-Body Therapies, Quality of Life, Health Promotion
Sex: All
Ages: 65 Years – 95 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 69
Sponsor: Cumhuriyet University
Location: Sivas Cumhuriyet University, Institute of Health Sciences Sivas Central
Summary
This interventional clinical trial was conducted to evaluate the effects of Antroyun (exergaming) and autogenic relaxation techniques on psychological well-being and life engagement among older adults living in nursing homes. Participants were randomly assigned to one of three groups: Antroyun intervention group, autogenic relaxation group, and a control group. Interventions were applied twice per week for eight weeks.
The results indicated that both interventions had a significant effect on improving psychological well-being and life engagement. The Antroyun group showed faster and more marked improvements in earlier follow-ups, while the autogenic relaxation group demonstrated sustained benefits in later follow-ups. The control group did not show any significant changes over time. Additionally, in the Antroyun group, the number of game wins was positively correlated with improvements in psychological well-being and life engagement scores.
This study was carried out as part of a doctoral dissertation at Sivas Cumhuriyet University.
Eligibility Criteria
Inclusion Criteria:
* Age 65 years or older
* Residing in a nursing home
* Able to communicate and follow instructions
* Scoring 24 or above on the Standardized Mini Mental Test (SMMT)
* Voluntary participation and written informed consent obtained
Exclusion Criteria:
* Diagnosed with advanced cognitive impairment (SMMT score \< 24)
* Diagnosed with severe psychiatric disorders (e.g., schizophrenia, severe depression)
* Having physical disabilities that prevent participation in the interventions (e.g., immobility, severe visual or auditory loss)
* Refusal or inability to provide informed consent
Source: ClinicalTrials.gov (NCT06965959). StuddyBuddy aggregates publicly available trial information.